Lundbeck Is Said to Express Interest in Xeris Biopharma

Fecha de publicación: 29 de septiembre de 2026, 16:33

H Lundbeck A/S has expressed interest in acquiring Xeris Biopharma Holdings Inc., a commercial-stage drugmaker, people familiar with the matter said.